Approval · Notice of Compliance 3772 · 1997
ESTRACOMB: Notice of Compliance 3772
Issued June 27, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3772
- Date
- June 27, 1997
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Estrogen-progestin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTRACOMB | 02108186 | Cancelled Post Market |
Medicinal ingredients
- ESTRADIOL 10 MG per PATCH
- NORETHINDRONE ACETATE 30 MG per PATCH
- ESTRADIOL 4 MG per PATCH